Author

Sawsan Elgohary

Observed name: S. Elgohary

Institution: German University in Cairo

Observed institution: German University in Cairo

ORCID: 0000-0002-1655-2665

Observed ORCID: 0000-0002-1655-2665

OpenAlex ID: A5064559153

Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?

2021 · Sawsan Elgohary, Aya A. Elkhodiry, et al. · Cells · 26

Inflammasomes in breast cancer: the ignition spark of progression and resistance?

2023 · Sawsan Elgohary, Hend M. El Tayebi · Expert Reviews in Molecular Medicine · 12

Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients

2023 · Sawsan Elgohary, Reda A. Eissa, et al. · International Journal of Molecular Sciences · 8

Suppressive effect of Thymoquinone on NLRP3 pathway in breast cancer: a novel multi-strike CALR and sec-PD-L1 inhibitor

2022 · Sawsan Elgohary, Reda A Eissa, et al. · Research Square

1764P A dose and time-dependent inhibitory effect of thymoquinone on inflammasome pathway in hormone receptor positive breast cancer: A novel personalized adjuvant therapy

2021 · S. Elgohary, R. Abdeltawab, et al. · Annals of Oncology

Works count: 5

Citation count: 46

H-index: 3

I10-index: 2